lobbying_filings_raw: 94de2575-68bb-45ae-98e4-84e304d87783
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94de2575-68bb-45ae-98e4-84e304d87783 | Q3 | 24338 | MCDERMOTT WILL & SCHULTE LLP | 131973 | SURESCRIPTS | 2020 | third_quarter | 2020-10-18T11:41:36.327000-04:00 | 60000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/94de2575-68bb-45ae-98e4-84e304d87783/", "filing_uuid": "94de2575-68bb-45ae-98e4-84e304d87783", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2020, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/94de2575-68bb-45ae-98e4-84e304d87783/print/", "filing_document_content_type": "text/html", "income": "60000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Karen Sealander", "dt_posted": "2020-10-18T11:41:36.327000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "500 North Capitol Street, NW", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20001", "registrant": {"id": 24338, "url": "https://lda.senate.gov/api/v1/registrants/24338/", "house_registrant_id": 31445, "name": "MCDERMOTT WILL & SCHULTE LLP", "description": "Law Firm", "address_1": "500 North Capitol Street, NW", "address_2": null, "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20001", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "ERIC ZIMMERMAN", "contact_telephone": "+1 202-204-1457", "dt_updated": "2026-01-14T11:28:33.077433-05:00"}, "client": {"id": 131973, "url": "https://lda.senate.gov/api/v1/clients/131973/", "client_id": 1006195, "name": "SURESCRIPTS", "general_description": "Health IT Company", "client_government_entity": false, "client_self_select": null, "state": "VA", "state_display": "Virginia", "country": "US", "country_display": "United States of America", "ppb_state": "VA", "ppb_state_display": "Virginia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2017-11-17"}, "lobbying_activities": [{"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Efforts to advance interoperability and to ensure technological advances in electronic prescribing benefit patients, prescribers and others in the pharmacy services benefits in a timely way, including improving the process for updating the SCRIPT electronic prescribing standard to allow for both testing and for more expeditious adoption of updated electronic prescribing standards.\n\nEfforts to ensure timely implementation of the SUPPORT Act requirement for electronic prescribing of controlled substances in the Medicare Part D program beginning January 1, 2021.\n\nEfforts to support CMSs proposed adoption of NCPDP SCRIPT Standard Version 2017071 for secure electronic prior authorization transactions for Part D-covered drugs and to ensure that problematic preamble language in the proposed rule is addressed so that electronic prior authorization by non-Part D prescription drug plans is not impeded by the final rule.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 41606, "prefix": null, "prefix_display": null, "first_name": "KAREN", "nickname": null, "middle_name": null, "last_name": "SEALANDER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 69050, "prefix": null, "prefix_display": null, "first_name": "SCOTT", "nickname": null, "middle_name": "AARON", "last_name": "WEINSTEIN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 18, "name": "Office of Management & Budget (OMB)"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Efforts to advance interoperability and to ensure technological advances in electronic prescribing benefit patients, prescribers and others in the pharmacy services benefits in a timely way, including improving the process for updating the SCRIPT electronic prescribing standard to allow for both testing and for more expeditious adoption of updated electronic prescribing standards.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 41606, "prefix": null, "prefix_display": null, "first_name": "KAREN", "nickname": null, "middle_name": null, "last_name": "SEALANDER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 69050, "prefix": null, "prefix_display": null, "first_name": "SCOTT", "nickname": null, "middle_name": "AARON", "last_name": "WEINSTEIN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 18, "name": "Office of Management & Budget (OMB)"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "SCI", "general_issue_code_display": "Science/Technology", "description": "Efforts to advance interoperability and to ensure technological advances in electronic prescribing benefit patients, prescribers and others in the pharmacy services benefits in a timely way, including improving the process for updating the SCRIPT electronic prescribing standard to allow for both testing and for more expeditious adoption of updated electronic prescribing standards.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 41606, "prefix": null, "prefix_display": null, "first_name": "KAREN", "nickname": null, "middle_name": null, "last_name": "SEALANDER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 69050, "prefix": null, "prefix_display": null, "first_name": "SCOTT", "nickname": null, "middle_name": "AARON", "last_name": "WEINSTEIN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 18, "name": "Office of Management & Budget (OMB)"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |